Newsroom

Portrait of Thomas Pietschmann, TWINCORE

Interview

About 70 million people worldwide are chronically infected with the hepatitis C virus (HCV). Possible consequences include hepatitis, cirrhosis and liver cancer, but the disease often remains undetected for long periods of time. Thomas Pietschmann of the TWINCORE in Hannover investigates the virus and works on the development of a vaccine that could prevent HCV infections in the future.

01.05.2019

TWINCORE

Interview

On average, every adult in Germany suffers from up to three respiratory infections per year. Although mostly caused by viruses, these infections are sometimes incorrectly treated with antibiotics. Dr. Stefanie Castell, deputy head of the HZI Department of Epidemiology, talks about a training project called WASA (“Wirksamkeit von Antibiotika-Schulungen in der niedergelassenen Ärzteschaft” – effectiveness of trainings on antibiotic prescription in primary care) that should improve the handling of antibiotic prescriptions.

01.11.2018

Interview

"Infections and Drugs" is one of four research topics of the Technische Universität Braunschweig. This positions TU Braunschweig as a close partner of the HZI. Their cooperation was the basis of the Systems Biology Centre BRICS that was established jointly in 2011. In an InFact interview, BRICS speaker Dieter Jahn, who is a professor of microbiology, explains how the TU Braunschweig and the HZI may benefit from each other in the long term.

16.04.2018

BRICS

Interview

Silke Tannapfel has been the Administrative Director of the HZI since 01 October 2017. A lawyer with a focus on science management, she previously directed the division for extramural research support of the Bavarian State Ministry for Economy and Media, Energy and Technology in Munich. InFact spoke to her about her professional challenges and the first days at the HZI.

01.12.2017

HZI Campus

Interview

The Hannover Medical School (MHH) has seen a great deal of change over the past few years: The school has recently undergone a phase of economic consolidation which also included a change of leadership. Prof Christopher Baum took over the role of President from Prof Dieter Bitter-Suermann four years ago – and inherited a whole host of collaboration projects with the HZI in the process. Christopher Baum spoke to InFact about the developments at the MHH and his plans for expanding the partnership with the HZI.

05.09.2017

TWINCORE

Interview

More and more pathogens are developing resistances to antibiotics. There is therefore an urgent need for new anti-infectives. In this regard, Eva Medina of the Helmholtz Centre for Infection Research is looking for therapeutic alternatives that will circumvent the renewed formation of antibiotic resistance.

03.04.2017

HZI Campus

HZI in the media

... der Pandemievorsorge. COMBINE wird vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig koordiniert und bringt ...

21.01.2025

DeutschesGesundheitsPortal

group leader at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, a site of the Braunschweig Helmholtz Centre for

20.01.2025

Applied Microbiology International

... des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) in Würzburg, einer Einrichtung des Braunschweiger Helmholtz- ...

20.01.2025

LaborPraxis

Braunschweig. Forscher des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig haben eine neuartige vielversprechende ...

19.01.2025

Regional Heute

... Zürich, die Universitätsmedizin Greifswald, das Helmholtz-Zentrum für Infektionsforschung (Braunschweig), die Universität zu ...

17.01.2025

Management & Krankenhaus

... ehemalige Gruppenleiterin am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger ...

17.01.2025

Bionity.COM